Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review

BACKGROUND: Conventional cytotoxic chemotherapy offers minor benefit to patients with mucosal melanoma (MM). Although immune checkpoint inhibitors (ICIs) have become the preferred approach in patients with advanced or metastatic cutaneous melanoma, the evidence of their clinical use for MM is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiarui, Kan, Haoxuan, Zhao, Lin, Sun, Zhao, Bai, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238311/
https://www.ncbi.nlm.nih.gov/pubmed/32489431
http://dx.doi.org/10.1177/1758835920922028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238311/
https://www.ncbi.nlm.nih.gov/pubmed/32489431
http://dx.doi.org/10.1177/1758835920922028

Ejemplares similares